Views

CrossRef citations to date

Altmetric

Review

Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era

Sherif M HamdyNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Maged Abdel-NaseerNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

https://orcid.org/0000-0002-2053-980X

Hatem S ShehataNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

https://orcid.org/0000-0002-4865-1457

Nevin M ShalabyNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Amr HassanNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

https://orcid.org/0000-0001-7374-7074

Alaa ElmaznyNeurology Department, Faculty of Medicine, Cairo University, Cairo, EgyptCorrespondence[email protected]

https://orcid.org/0000-0002-3556-3749

Ehab ShakerNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Mona A F NadaNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

https://orcid.org/0000-0002-8969-8825

Sandra M AhmedNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Mohamed I HegazyNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

https://orcid.org/0000-0001-5012-3998

Husam S MouradNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

https://orcid.org/0000-0002-1994-3186

Ahmed AbdelalimNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

https://orcid.org/0000-0001-6445-5539

Rehab MagdyNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Alshimaa S OthmanNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

https://orcid.org/0000-0003-0976-9011

Doaa A MekkawyNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Nirmeen A KishkNeurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

https://orcid.org/0000-0003-4410-7814

show all

Abstract

The ongoing coronavirus (COVID-19) pandemic is a global health emergency of international concern and has affected management plans of many autoimmune disorders. Immunosuppressive and immunomodulatory therapies are pivotal in the management of neuromyelitis optica spectrum disorder (NMOSD), potentially placing patients at an increased risk of contracting infections such as COVID-19. The optimal management strategy of NMOSD during the COVID-19 era remains unclear. Here, however, we examined the evidence of NMOSD disease-modifying therapies (DMTs) use during the present period and highlighted different scenarios including treatment of relapses as well as initiation and maintenance of DMTs in order to optimize care of NMOSD patients in the COVID-19 era.

Keywords:

Disclosure

The authors report no conflicts of interest in this work.

Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era

Information for

Open access

Opportunities

Help and information

Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era

Abstract

Disclosure

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature